Antibody-mediated rejection criteria - an addition to the Banff '97 Classification of Renal Allograft Rejection

被引：848

作者：

Racusen, LC ^{[1
]}

Colvin, RB

Solez, K

Mihatsch, MJ

Halloran, PF

Campbell, PM

Cecka, MJ

Cosyns, JP

Demetris, AJ

Fishbein, MC

Fogo, A

Furness, P

Gibson, IW

Glotz, D

Hayry, P

Hunsickern, LN

Kashgarian, M

Kerman, R

Magil, AJ

Montgomery, R

Morozumi, K

Nickeleit, V

Randhawa, P

Regele, H

Seron, D

Seshan, S

Sund, S

Trpkov, K

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

[3] Univ Alberta, Edmonton, AB, Canada

[4] Univ Basel, Basel, Switzerland

[5] Univ Calif Los Angeles, Los Angeles, CA USA

[6] Catholic Univ Louvain, Sch Med, Brussels, Belgium

[7] Univ Pittsburgh, Pittsburgh, PA USA

[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[9] Vanderbilt Univ, Nashville, TN USA

[10] Univ Leicester, Leicester, Leics, England

[11] Hlth Sci Ctr, Winnipeg, MB, Canada

[12] Hop Europeen Georges Pompidou, Paris, France

[13] Univ Helsinki, Helsinki, Finland

[14] Univ Iowa, Iowa City, IA USA

[15] Yale Univ, New Haven, CT USA

[16] Univ Texas, Houston, TX USA

[17] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada

[18] Nagoya City Univ, Nagoya, Aichi, Japan

[19] Univ N Carolina, Chapel Hill, NC USA

[20] Univ Vienna, Vienna, Austria

[21] Univ Barcelona, Barcelona, Spain

[22] Cornell Med Ctr, New York, NY USA

[23] Natl Hosp, Oslo, Norway

[24] Rockyview Gen Hosp, Calgary, AB, Canada

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2003年 / 3卷 / 06期

关键词：

antibody; Banff; pathology; rejection;

D O I：

10.1034/j.1600-6143.2003.00072.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

引用

页码：708 / 714

页数：7

共 25 条

[11] THE SIGNIFICANCE OF THE ANTI-CLASS-I ANTIBODY-RESPONSE .1. CLINICAL AND PATHOLOGICAL FEATURES OF ANTI-CLASS I-MEDIATED REJECTION [J].